For columnist Tanita Allen, humor often serves as a coping mechanism in life with Huntington's. But sometimes it's more harmful than helpful.| Huntington's Disease News
Speakers at the 2025 HDSA convention highlighted clinical trials testing several treatments aimed at mutant huntingtin.| Huntington's Disease News
Early care planning helps Huntington's patients and families cope as the disease progresses, speakers at the HDSA annual convention said.| Huntington's Disease News
Participating in dance classes may help people with Huntington's disease improve their balance and maintain their functional capacity.| Huntington's Disease News
A genetic disease like Huntington's affects the entire family tree, not just those who inherit the condition, says columnist Carlos Briceño.| Huntington's Disease News
No description.| Huntington's Disease News
Ingrezza's effects on Huntington's-associated chorea appear stronger over time, according to an analysis of the Phase 3 KINECT-HD trial.| Huntington's Disease News
Ingrezza has been associated with sustained reductions in Huntington's chorea, regardless of concurrent antipsychotic medication use.| Huntington's Disease News
Columnist Carlos Briceño says it's not Huntington's that defines his wife, Jill, but rather her fighting spirit and fierce attitude.| Huntington's Disease News
Marisa Wexler is a senior science writer for Huntington's Disease News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Walking, aerobics, and strength training have been shown to help people with Huntington’s to stay active and maintain their mobility.| Huntington's Disease News
Two proteins, neurofilament light chain and phosphorylated tau, can serve as markers of Huntington's disease progression, a study found.| Huntington's Disease News
An oral granule formulation of Ingrezza, called Ingrezza Sprinkle, has been granted FDA approval for treating Huntington's-associated chorea.| Huntington's Disease News
Ingrezza is an oral medication approved in the U.S. for chorea, or the involuntary, jerky movements that characterize Huntington’s disease.| Huntington's Disease News
Category archive page for News.| Huntington's Disease News
Mutant huntingtin protein may drive nerve cell death by poking holes in the membrane that surrounds and protects cells' DNA-filled core.| Huntington's Disease News
Columnist Carlos Briceño and his wife with Huntington's, Jill, have a wish list for whoever becomes the new president of the HDSA.| Huntington's Disease News